Cargando…

ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer

Detalles Bibliográficos
Autores principales: Matikas, A., Lambertini, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910736/
https://www.ncbi.nlm.nih.gov/pubmed/33399079
http://dx.doi.org/10.1016/j.esmoop.2020.100014
_version_ 1783656181810593792
author Matikas, A.
Lambertini, M.
author_facet Matikas, A.
Lambertini, M.
author_sort Matikas, A.
collection PubMed
description
format Online
Article
Text
id pubmed-7910736
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79107362021-03-04 ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer Matikas, A. Lambertini, M. ESMO Open Podcast Elsevier 2020-12-15 /pmc/articles/PMC7910736/ /pubmed/33399079 http://dx.doi.org/10.1016/j.esmoop.2020.100014 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Podcast
Matikas, A.
Lambertini, M.
ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer
title ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer
title_full ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer
title_fullStr ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer
title_full_unstemmed ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer
title_short ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer
title_sort esmo20 yo for yo: highlights on adjuvant cdk4/6 inhibitors in early hormone receptor-positive/her2-negative breast cancer
topic Podcast
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910736/
https://www.ncbi.nlm.nih.gov/pubmed/33399079
http://dx.doi.org/10.1016/j.esmoop.2020.100014
work_keys_str_mv AT matikasa esmo20yoforyohighlightsonadjuvantcdk46inhibitorsinearlyhormonereceptorpositiveher2negativebreastcancer
AT lambertinim esmo20yoforyohighlightsonadjuvantcdk46inhibitorsinearlyhormonereceptorpositiveher2negativebreastcancer